# Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors

> **NCT07301814** · — · RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 56 (estimated)

## Conditions studied

- Gastric Cancer
- Pancreatic Cancer
- Cholangiocarcinoma Cancer
- Esophageal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Specific PET imaging agents targeting CLDN18.2

## Key facts

- **NCT ID:** NCT07301814
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07301814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07301814, "Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT07301814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*